ReviewJournal of clinical medicine2019

Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Strategies for In Vivo Administration: Part-II.

Raquel Vieira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.